U.S. Vitrification Market Size, Share & Trends Analysis Report, By Specimen (Oocytes, Embryo, Sperm), By End-use (IVF Clinics, Biobanks), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Specimen
                        1.2.2. End-use
                        1.2.3. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Specimen Outlook
                        2.2.2. End-use Outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Vitrification Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                        3.2.3. Market opportunity analysis
                    3.3. U.S. Vitrification Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. U.S. Vitrification Market: Specimen Estimates & Trend Analysis
                    4.1. U.S. Vitrification Market: Specimen Dashboard
                    4.2. U.S. Vitrification Market: Specimen Movement Analysis
                    4.3. U.S. Vitrification Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    4.4. Oocytes
                        4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.2. Devices
                            4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.3. Kits & Consumables
                            4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.5. Embryo
                        4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.5.2. Devices
                            4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.5.3. Kits & Consumables
                            4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.6. Sperm
                        4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Vitrification Market: End-use Estimates & Trend Analysis
                    5.1. U.S. Vitrification Market: End-use Dashboard
                    5.2. U.S. Vitrification Market: End-use Movement Analysis
                    5.3. U.S. Vitrification Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    5.4. IVF Clinics
                        5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.5. Biobanks
                        5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Recent Developments & Impact Analysis, By Key Market Participants
                    6.2. Company/Competition Categorization
                    6.3. Vendor Landscape
                        6.3.1. List of key distributors and channel partners
                        6.3.2. Key customers
                        6.3.3. Key company market share analysis, 2023
                        6.3.4. Cook Medical LLC
                            6.3.4.1. Company overview
                            6.3.4.2. Financial performance
                            6.3.4.3. Product benchmarking
                            6.3.4.4. Strategic initiatives
                        6.3.5. Vitrolife
                            6.3.5.1. Company overview
                            6.3.5.2. Financial performance
                            6.3.5.3. Product benchmarking
                            6.3.5.4. Strategic initiatives
                        6.3.6. Genea Biomedx
                            6.3.6.1. Company overview
                            6.3.6.2. Financial performance
                            6.3.6.3. Product benchmarking
                            6.3.6.4. Strategic initiatives
                        6.3.7. NidaCon International AB
                            6.3.7.1. Company overview
                            6.3.7.2. Financial performance
                            6.3.7.3. Product benchmarking
                            6.3.7.4. Strategic initiatives
                        6.3.8. Minitube
                            6.3.8.1. Company overview
                            6.3.8.2. Financial performance
                            6.3.8.3. Product benchmarking
                            6.3.8.4. Strategic initiatives
                        6.3.9. IMV Technologies Group (Cryo Bio System)
                            6.3.9.1. Company overview
                            6.3.9.2. Financial performance
                            6.3.9.3. Product benchmarking
                            6.3.9.4. Strategic initiatives
                        6.3.10. The Cooper Companies, Inc. (A CooperSurgical Fertility Company)
                            6.3.10.1. Company overview
                            6.3.10.2. Financial performance
                            6.3.10.3. Product benchmarking
                            6.3.10.4. Strategic initiatives
                        6.3.11. FUJIFILM Corporation (FUJIFILM Irvine Scientific)
                            6.3.11.1. Company overview
                            6.3.11.2. Financial performance
                            6.3.11.3. Product benchmarking
                            6.3.11.4. Strategic initiatives
                        6.3.12. Biotech, Inc.
                            6.3.12.1. Company overview
                            6.3.12.2. Financial performance
                            6.3.12.3. Product benchmarking
                            6.3.12.4. Strategic initiatives
                        6.3.13. Kitazato Corporation
                            6.3.13.1. Company overview
                            6.3.13.2. Financial performance
                            6.3.13.3. Product benchmarking
                            6.3.13.4. Strategic initiatives
                        6.3.14. Shenzhen VitaVitro Biotech
                            6.3.14.1. Company overview
                            6.3.14.2. Financial performance
                            6.3.14.3. Product benchmarking
                            6.3.14.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 U.S. vitrification market, 2018 - 2030 (USD Million)
Table 3 U.S. vitrification market, by specimen, 2018 - 2030 (USD Million)
Table 4 U.S. vitrification market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. vitrification market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Product and stage segment snapshot
Fig. 11 Sales channel segment snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. vitrification market: Specimen outlook and key takeaways
Fig. 16 U.S. vitrification market: Specimen movement analysis
Fig. 17 Oocytes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Kits & consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Embryo market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Kits & consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Sperm market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 U.S. vitrification market: End-use outlook and key takeaways
Fig. 25 U.S. vitrification market: End-use movement analysis
Fig. 26 IVF clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Biobanks market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Company market share analysis, 2023
Fig. 29 Strategic framework